Geron Q3 EPS $(0.08) Beats $(0.10) Estimate, Sales $164.00K Beat $59.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Geron (NASDAQ:GERN) reported Q3 losses of $(0.08) per share, beating the analyst consensus estimate of $(0.10) by 20%. The company also reported quarterly sales of $164.00K, surpassing the analyst consensus estimate of $59.00K by 177.97%. However, this represents a 44.78% decrease in sales compared to the same period last year.
November 02, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Geron's Q3 earnings beat analyst estimates both in terms of EPS and sales. However, the company's sales have decreased compared to the same period last year.
While Geron's Q3 earnings beat analyst estimates, indicating a potential positive impact on the stock, the decrease in sales compared to the same period last year could offset this positive impact, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100